These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-003053-26 The ZBMUF trial: an open-label randomised study of the effects of ultra-filtration and high dose aprotinin on bivalirudin pharmacokinetics during and/or after cardiopulmonary bypass surgery 2007-06-22 due-trials
Listed as ongoing, but also has a completion date 2006-000192-14 A clinical trial comparing cangrelor to clopidogrel in subjects who require percutaneous coronary intervention. 2010-06-17 bad-data
Listed as ongoing, but also has a completion date 2006-003935-56 A clinical trial comparing treatment with cangrelor (in combination with usual care) to usual care, in subjects who require percutaneous coronary intervention 2010-05-25 bad-data
Not reported 2008-000230-53 The evaluation of patients with acute hypertension and intracerebral hemorrhage with intravenous clevidipine treatment 2010-04-25 due-trials
Reported results 2008-001135-35 Maintenance of platelet inhiBition with cangreloR after dIscontinuation of thienopyriDines in patients undergoing surGEry: The BRIDGE trial 2011-06-06 due-trials
Not reported 2008-003676-22 A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure – A Pilot Study (PRONTO) 2012-04-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-007290-20 Ensayo europeo en ambulancias para tratar el síndrome coronario agudo: EUROMAX 2014-12-20 bad-data
Listed as ongoing, but also has a completion date 2010-021424-94 A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin versus IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin St... 2012-11-30 bad-data
Not reported 2010-021591-28 A clinical trial comparing cangrelor to clopidogrel standard of care therapy in subjects who require percutaneous coronary intervention 2012-11-14 due-trials
Listed as ongoing, but also has a completion date 2010-021720-10 A Multicenter, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Single-Dose IV Oritavancin versus IV Vancomycin for the Treatment of Patients with Acute Bacterial Skin and Skin St... 2013-06-20 bad-data
Ongoing 2011-004666-15 A Phase II, double-blind, parallel group, dose-selection study to compare antifibrinolytic MDCO-2010 vs. placebo and tranexamic acid in reducing blood loss in patients undergoing primary cardiac surge... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-000632-26 Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 2015-06-24 bad-data
Completed, but no date, and reported results 2012-002314-39 Bivalirudin Infusion for Ventricular Infarction Limitation bad-data
Trial is outside EEC 2013-005415-26 An Open label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of Oritavancin Single Dose Infusion in Pediatric Subjects Less Than 18 Years of Age with Suspected or Confirmed Bacterial ... bad-data
Not reported 2014-000816-32 A Phase 3b, Randomized, Single-Blind, Controlled, Comparative Efficacy and Safety Study of Topical Fibrocaps™ (Raplixa™) and Tachosil® in Surgical Hemostasis during Hepatic Resection 2015-08-12 due-trials
Trial is outside EEC, and reported results 2014-002405-37 An open label evaluation of the safety and clinical utility of the active, separated system with enhanced controller (SSEC) fentanyl 40 mcg for the management of acute postoperative pain in pediatric ... bad-data
Completed, but no date Terminated 2014-005462-30 A multiple dose, dose-finding, placebo controlled, double blind, randomized trial to compare the effect of treatment on plaque burden as determined by intravascular ultrasound and evaluate the efficac... bad-data
Reported results 2015-000826-13 A placebo-controlled, double-blind, randomized trial to compare the effect of treatment on plaque burden as determined by intravascular ultrasound and to evaluate the efficacy, pharmacokinetics, safet... 2016-10-26 due-trials
Reported results 2015-003772-74 A placebo-controlled, double-blind, randomized trial to compare the effect of different doses of ALN-PCSSC given as single or multiple subcutaneous injections in subjects with high cardiovascular risk... 2017-06-07 due-trials
Completed, but no date Terminated 2015-004019-19 A phase II, two-part, multiple-dose, dose-finding, single-blind study to investigate the safety and efficacy of ABP-700 for procedural sedation in adult patients undergoing colonoscopy bad-data
Completed, report not yet due 2016-003376-49 An Open-Label, Single-Arm, Multicenter Pilot Study to Evaluate Safety, Tolerability, and Efficacy of ALN-PCSSC in Subjects with Homozygous Familial Hypercholesterolemia 2018-10-08 not-yet-due
Ongoing 2016-003815-37 An open label, active comparator extension trial to assess the effect of long term dosing of inclisiran and evolocumab given as subcutaneous injections in subjects with high cardiovascular risk and el... not-yet-due
Ongoing 2017-001846-90 A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED TRIAL TO EVALUATE THE EFFECT OF 300 MG OF INCLISIRAN SODIUM GIVEN AS SUBCUTANEOUS INJECTIONS IN SUBJECTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASC... not-yet-due
Ongoing 2017-002472-30 A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED TRIAL TO EVALUATE THE EFFECT OF 300 MG OF INCLISIRAN SODIUM GIVEN AS SUBCUTANEOUS INJECTIONS IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA ... not-yet-due
Ongoing 2017-003092-55 A long term extension trial of the Phase III lipid-lowering trials to assess the effect of long term dosing of inclisiran given as subcutaneous injections in subjects with high cardiovascular risk and... not-yet-due
Ongoing 2017-005066-22 HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease not-yet-due